Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |